HomeIMAGING

IMAGING

New Apollo eBook Explores Multidisciplinary Patient-Centric Approach to Enterprise Imaging

Apollo eBook introduces a paradigm shift in enterprise imaging, explaining how a multidisciplinary, patient-centric approach ensures improved patient outcomes, thinking beyond the radiology workflow to reflect both the workflows of other specialties and medical encounters.

Vieworks Showcases X-ray Imaging Excellence: RSNA 2023 Spotligh

Vieworks will present its comprehensive range of DR flat panel detectors (FPDs) catering to general radiography, dynamic applications, and mammography. The focal point remains on the latest VIVIX-S F series, accompanied by the revolutionary VIVIX-S 1751S—a long-format detector tailored for imaging larger body parts and long bones.

Samsung Ushers in a New Era of Diagnostic Solutions at RSNA 2023

The clinical launch of the OmniTom Elite with PCD, the first US FDA 510(k) cleared single-source photon counting computed tomography scanner with a single detector on a mobile system, will be featured at this year’s meeting. Photon counting is a next-generation CT technology that sorts the different energies of X-rays after they have passed through the scan field, capturing the X-ray photons directly at the detector and converting the energy to electrical signals.

Olympus Announces Market Launch of EVIS X1 Endoscopy System

The EVIS X1 endoscopy system received clearance earlier this year along with two compatible endoscopes: the GIF-1100 gastrointestinal videoscope indicated for use within the upper digestive tract and the CF-HQ1100DL/I colonovideoscope indicated for use within the lower digestive tract.

Philips Announces New Interoperability Capabilities that Offer a Comprehensive View of Patient Health for Improved Monitoring and Care Coordination

As a world leader monitoring more than 600 million patients each year worldwide, Philips is creating an open patient monitoring ecosystem to bring together disparate medical devices and systems on a single interface. Interoperability between MDIP and PIC iX gives clinicians a new clinical perspective that enables the capture of streaming data flowing freely from a variety of medical device manufacturers on an open, scalable, secure platform. By disseminating this information through the Patient Information Center, clinicians have a single source, comprehensive overview of a patient’s condition that helps empower caregivers to make treatment recommendations confidently from anywhere throughout the hospital’s digital environment.

Phillips-Medisize Teams with GlucoModicum to Develop an Innovative Needle-Free Continuous Glucose Monitor

GlucoModicum is an innovative medtech company based in Finland, to design and eventually commercialize a proprietary non-invasive, wearable device that removes technology and patient-care roadblocks to continuous glucose monitoring (CGM).

Fujitsu and iSurgery Launch Bone Health Promotion Project in Japan with Jikei University School of Medicine Aiming for Early Detection of Osteoporosis

In this demonstration, the project group will utilize iSurgery's AI medical device, the medical image analysis software Chest Bone Indicator (3) (AI medical device), to assess bone health from chest radiographs and notify the results of health examinations for Fujitsu Group employees.

Combining best-in-class AI-powered Technologies for Musculoskeletal (MSK) Imaging Workflows – ImageBiopsy Lab and Radiobotics sign Collaboration Agreement

Dr. Richard Ljuhar, CEO and Co-Founder of ImageBiopsy Lab, explains, "Before even considering the use of AI, it's crucial to grasp physicians' diagnostic workflow and needs. For this purpose we've closely collaborated with leading MSK radiologists, orthopaedics, and traumatologists over the past years. We're committed to revolutionizing the entire MSK diagnostic value chain for practitioners, patients, and healthcare systems.

Lunit’s AI-Powered Mammography Analysis Solution Achieves Comparable Diagnostic Performance with Human Readers

"This first study to apply the Personal Performance in Mammographic Screening (PERFORMS) scheme to AI algorithms marks a remarkable achievement, showcasing our AI's ability to match human performance in detecting breast cancer. It offers hope to patients worldwide and underscores AI's potential to enhance cancer detection and treatment outcomes," said Brandon Suh, CEO of Lunit.